| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |